HMGB1 and hepatocellular carcinoma: Previous studies have reported the HMGB1 polymorphisms might efficiently predict the risk of susceptibility to different cancers such as hepatocellular carcinoma, uterine cervical neoplasia as well as colorectal cancer [31,32,33,34].